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Letters to the Editor
Peritonitis  by  Shewanella  putrefaciens:  Apropos  of  a  caseen
in PD of the importance of properly covering the catheterPeritonitis  por  Shewanella  putrefaci
Dear Editor,
Peritonitis is an inﬂammation of the peritoneal membrane
caused by infection, generally bacterial. It remains the most
signiﬁcant complication deriving from the dialysis technique
itself.
Shewanella putrefaciens is an oxidase-positive, facultative
anaerobic, non-fermenting, Gram-negative bacillus found
mainly in marine environments.
It is an uncommon pathogen in human beings, mainly
causing skin and soft-tissue infection.1–4
We  report a case of S. putrefaciens peritonitis in a 40-year-
old woman with Takayasu arteritis and stage 5 chronic kidney
disease in automated peritoneal dialysis (PD) since February
2009. In June 2014, she visited the emergency department
owing to fever and abdominal pain for the last 12 h. Mesenteric
ischaemia was ruled out by means of a CT scan. Subsequently,
the peritoneal ﬂuid was drained and peritoneal ﬂuid with a
cloudy, yellowish appearance was observed. A physical exam-
ination revealed diffuse abdominal pain, and an inspection of
the catheter outlet revealed no signs of local infection.
A peritoneal ﬂuid count showed 20,160 cells with 81% poly-
morphonuclear cells, and samples were collected for culture.
Blood clinical chemistry showed neutrophilia,
normochromic normocytic anaemia and high levels of acute-
phase reactants and procalcitonin. She was admitted given
her compromised general condition and persistent fever.
Antibiotic therapy was started with intraperitoneal van-
comycin and ceftazidime, according to our hospital’s protocol.
Multisensitive S. putrefaciens and Klebsiella oxytoca were
isolated in a peritoneal ﬂuid culture. Blood cultures were neg-
ative.
After identiﬁcation of the responsible pathogen, treat-
ment with vancomycin was suspended, treatment with
intraperitoneal ceftazidime was maintained and oral
ciproﬂoxacin and ﬂuconazole were added.The patient progressed satisfactorily; she became afebrile
and asymptomatic and her laboratory parameters returned to
normal. She was discharged and remained in PD.
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The Shewanella genus is found throughout numerous geo-
graphic areas with moderate climates, mainly in humid
environments (saltwater, freshwater and wastewater). How-
ever, it is also present in natural energy reserves (petroleum
and gas), dairy products, meat and human samples.
It tends to isolate itself by becoming a part of a mixed bac-
terial ﬂora; therefore, its clinical signiﬁcance may be obscured
by the other microorganisms. It causes various types of
syndromes, and is found in patients with infectious endo-
carditis, bacteraemia, lower limb abscesses, soft-tissue or
intra-abdominal infections in patients in PD, pneumonia asso-
ciated with the use of mechanical ventilation, eye infections
and brain abscesses.5
The S. putrefaciens pathogen tends to be sensitive to amino-
glycosides, carbapenems, erythromycin and quinolones.
The pathogenesis and the site of entry of the infection
remain poorly established. Proximity to seawater or tap water
renders these media potential sources of infection.
There are 6 published cases of S. putrefaciens peritonitis
in patients in PD – Taiwan, Australia, Israel and the United
States5 – with a variety of clinical manifestations, concomi-
tant bacteraemia and, sometimes, a fatal outcome, as in the
case of peritonitis with necrotising fasciitis in Korea, the case
of peritonitis with spleen abscess from the Australian group,
and even other cases with fulminant periorbital – facial celluli-
tis, biliary tract infection, empyema  or perianal abscess. The
majority of these patients had factors such as malignant neo-
plasm, hepatobiliary disease, neutropenia, etc. Renal failure
may also represent a risk factor.
The case presented seems to be the ﬁrst documented
case in Spain. After an exhaustive medical history we  were
unable to identify a clear source of exposure. Our only
clue was that the patient had a high level of exposure to
seawater.
Whatever the mechanism, it seems wise to warn patientsE, Chamorro Buchelli I, Guerra Rodriguez R, Auyanet Saavedra I,
e un caso. Nefrologia. 2016;36:444–445.
outlet and any potential site of infection such as ulcers. In
addition, although this type of peritonitis is uncommon, a
potentially serious cause of peritonitis should be considered
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patients. However, it can generally be treated on an outpatientn e f r o l o g i a. 2 0 
nd a skin lesion or portal of entry should be heeded as a
otential warning, especially in patients with a history of
xposure to seawater.
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eritonitis  causada  por  Paracoccus  
ear Editor,
eritonitis is deﬁned as peritoneal inﬂammation caused by
icroorganisms, with the presence of cloudy peritoneal ﬂuid,
 leukocyte count of more  than 100 per microlitre and leuko-
ytes accounting for more  than 50% of polymorphonuclear
ells. It remains the most signiﬁcant complication deriving
rom the dialysis technique itself. It is generally caused by
ram-positive skin bacteria such as Staphylococcus epidermidis
nd Staphylococcus aureus,  or by enterobacteria and fungi.
n intact peritoneum and the defence mechanisms of the
esothelium are probably the most signiﬁcant barriers that
elp prevent the development of peritonitis. Prevention is the
undamental weapon, and the routes by which microorgan-
sms enter the peritoneal cavity should be acted on: peritoneal
ccess, connection systems, dialysis solutions and examina-
ions that help enable infection.
Paracoccus yeei is a non-fermenting bacterium in the envi-
onment that is present in soil. It is the bacterium that caused
he episode of peritonitis in the case that we are reporting.
Our case is a 46-year-old woman diagnosed with adult poly-
ystic kidney disease, on a regimen of automated peritoneal
ialysis for the last 3 years, with no prior episodes of peritoni-
is. The patient lived with a small dog she routinely take out
or walks.
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toneal  dialysis
i  en  diálisis  peritoneal
She visited the dialysis unit because she noticed cloudy
ﬂuid in the peritoneal efﬂuent drainage. There was no fever
or nausea, and her bowel movements were normal. She had
slight abdominal discomfort, and an examination showed
signs of peritoneal irritation. A peritoneal ﬂuid cell count was
performed and found 790 leukocytes/mcl, with 75% polymor-
phonuclear cells. Samples were sent for the performance of
a Gram stain, and cultures in blood culture and conventional
media. A diagnosis of peritonitis was conﬁrmed and treatment
was started according to our site’s protocol, with intraperi-
toneal vancomycin and ceftazidime. Empirical treatment of
peritonitis was to be done with a combination of broad spec-
trum antibiotics targeting Gram-positive and Gram-negative
microorganisms. The patient continued on an outpatient
regimen, since her general condition was good, with daily self-
administration of intraperitoneal ceftazidime and visits to the
hospital to undergo follow-up cell counts. At 48 h she received
a positive culture in a blood culture medium for Paracoccus yeei.
No bacteria were seen on a Gram stain, and a conventional
culture was negative. Peritonitis results in morbidity and mor-
tality, and is a cause of hospitalization in the most impairedk I, Marin˜o S, Lucas C, Monfá E, et al. Paracoccus yeei peritonitis in
basis, as in our case.
Paracoccus yeei was formerly classiﬁed as a eugonic oxidizer
group 2 (EO-2) strain. In 2003, new molecular techniques iden-
